Tubulis is a Munich-based biotech company developing antibody-drug conjugate (ADC) technologies and oncology therapeutics for targeted cancer treatment.
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| €308 M | Oct, 2025 | series-c |
| $3.15 B | Apr, 2026 | acquisition |
Frequently Asked Questions
Where is Tubulis located?
Tubulis is located in Munich, Germany.
What industries does Tubulis operate in?
Tubulis operates in the following industries: biotechnology, oncology, antibody-drug conjugates, healthcare.
How much total funding has Tubulis raised?
Tubulis has raised a total of $3,458,000,000.
Who are the investors in Tubulis?
The investors in Tubulis are: Venrock Healthcare Capital Partners, Wellington Management, Ascenta Capital, Nextech Invest, EQT Life Sciences, Frazier Life Sciences, Andera Partners, Deep Track Capital, Bayern Kapital, Fund+, OCCIDENT, Seventure Partners, High-Tech Gründerfonds (HTGF), Gilead Sciences.
Who are the founders of Tubulis?
The founders of Tubulis are: Dominik Schumacher.
What is the primary mission of Tubulis?
Tubulis is dedicated to the development of next-generation antibody-drug conjugates that aim to expand the therapeutic potential of cancer treatments through enhanced stability and efficacy.
What proprietary technologies does Tubulis utilize?
The company employs a specialized technological toolkit including the P5 conjugation platform and Tubutecan payloads to create highly stable and versatile therapeutic candidates.
Where is the headquarters of Tubulis located?
The biotechnology firm is based in Munich, Germany, where it conducts its core research and development operations.
How does Tubulis aim to improve antibody-drug conjugates?
By focusing on site-specific conjugation and novel payload designs, the company seeks to overcome the limitations of traditional therapies, such as off-target toxicity and molecular instability.
What is the main therapeutic focus area for Tubulis?
The company primarily targets oncology, developing innovative treatments for various types of solid tumors and other high-need medical conditions.